Erratum: Redox dependence of glomerular epithelial cell hypertrophy in response to glucose (American Journal of Physiology - Renal Physiology (2006) 290, (F741-F751) DOI: 10.1152/ajprenal.00313.2005);Redox dependence of glomerular epithelial cell hypertrophy in response to glucose

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 3, 2006, Pages

  Kim, Nam Ho ^a,b   Rincon Choles, Hernan ^a,c   Bhandari, Basant ^a   Choudhury, Goutam Ghosh ^a,b,c   Abboud, Hanna E ^a,b   Gorin, Yves ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b Chonnam National University Medical School   (South Korea)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Angiotensin II; High glucose; Hypertrophy; Podocytes; Protein synthesis; Reactive oxygen species

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; ANGIOTENSIN II; ANTIOXIDANT; CATALASE; DIPHENYLIODONIUM SALT; GLUCOSE; HYDROGEN PEROXIDE; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRITIUM; MANNITOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; GLOMERULUS EPITHELIUM; HYPERTROPHY; NONHUMAN; OXIDATION REDUCTION REACTION; PODOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; ANIMAL; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; GLOMERULUS; KINETICS; MALE; PATHOLOGY;

ANIMALS; CELLS, CULTURED; EPITHELIAL CELLS; GLUCOSE; HYPERTROPHY; KIDNEY GLOMERULUS; KINETICS; MALE; MANNITOL; OXIDATION-REDUCTION; PODOCYTES; RATS;

EID: 33645569518     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00121.2006     Document Type: Erratum

References (56)

1. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, and Marrero MB. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 61: 1605-1616, 2002.
2. Amiri F, Venema VJ, Wang X, Ju H, Venema RC, and Marrero MB. Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells. J Biol Chem 274: 32382-32386, 1999.
3. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, and Wilcox CS. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67: 1890-1898, 2005.
4. Barisoni L and Kopp JB. Update in podocyte biology: putting one's best foot forward. Curr Opin Nephrol Hypertens 12: 251-258, 2003.
5. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625, 2005.
6. Carey RM and Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 14: 274-281, 2003.
7. Chen K, Thomas SR, Albano A, Murphy MP, and Keaney JF Jr. Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J Biol Chem 279: 35079-35086, 2004.
8. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, and Floege J. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 57: 167-182, 2000.
9. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, and Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52: 1031-1035, 2003.
10. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
11. Fujita H, Omori S, Ishikura K, Hida M, and Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells. Am J Physiol Renal Physiol 286: F120-F126, 2004.
12. Fujita H, Omori S, Ishikura K, Hida M, and Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells. Am J Physiol Renal Physiol 286: F120-F126, 2004.
13. Gassler N, Elger M, Kranzlin B, Kriz W, Gretz N, Hahnel B, Hosser H, and Hartmann I. Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat. Kidney Int 60: 106-116, 2001.
14. Gorin Y, Kim NH, Feliers D, Bhandari B, Choudhury GG, and Abboud HE. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J 15: 1909-1920, 2001.
15. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, and Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285: F219-F229, 2003.
16. Gorin Y, Ricono JM, Wagner B, Kim NH, Bhandari B, Choudhury GG, and Abboud HE. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 381: 231-239, 2004.
17. Greiber S, Munzel T, Kastner S, Muller B, Schollmeyer P, and Pavenstadt H. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int 53: 654-663, 1998.
18. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, and Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46: 847-853, 1997.
19. Kip1: role in angiotensin II-mediated hypertrophy of proximal tubular cells. J Am Soc Nephrol 11: 1387-1397, 2000.
20. Hixon ML, Muro-Cacho C, Wagner MW, Obejero-Paz C, Millie E, Fujio Y, Kureishi Y, Hassold T, Walsh K, and Gualberto A. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest 106: 1011-1020, 2000.
21. Hoffmann S, Podlich D, Hahnel B, Kriz W, and Gretz N. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 15: 1475-1487, 2004.
22. Hoshi S, Nomoto K, Kuromitsu J, Tomari S, and Nagata M. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 290: 177-184, 2002.
23. Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, and Nagata M. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 82: 25-35, 2002.
24. 2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. J Biol Chem 278: 33951-33962, 2003.
25. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
26. Kreisberg JI, Hoover RL, and Karnovsky MJ. Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 14: 21-30, 1978.
27. Lee HB, Yu MR, Yang Y, Jiang Z, and Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14: S241-S245, 2003.
28. Li JM and Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14: S221-S226, 2003.
29. Marshall CB and Shankland SJ. Cell cycle and glomerular disease: a minireview. Nephron Exp Nephrol 102: e39-e48, 2005.
30. Marshall SM. Recent advances in diabetic nephropathy. Clin Med 4: 277-282, 2004.
31. Mifsud SA, Allen TJ, Bertram JF, Hulthen UL, Kelly DJ, Cooper ME, Wilkinson-Berka JL, and Gilbert RE. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade. Diabetologia 44: 878-882, 2001.
32. Mundel P and Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002.
33. Natarajan R, Scott S, Bai W, Yerneni KK, and Nadler J. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 33: 378-384, 1999.
34. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, and Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 90: 3645-3649, 1993.
35. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, and Meyer TW. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997.
36. Pavenstadt H, Kriz W, and Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003.
37. Petermann AT, Pippin J, Durvasula R, Pichler R, Hiromura K, Monkawa T, Couser WG, and Shankland SJ. Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int 67: 157-166, 2005.
38. +-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol Cell Biol 25: 575-589, 2005.
39. Senthil D, Choudhury GG, McLaurin C, and Kasinath BS. Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy. Kidney Int 64: 468-479, 2003.
40. Shaw S, Wang X, Redd H, Alexander GD, Isales CM, and Marrero MB. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem 278: 30634-30641, 2003.
41. Sheu ML, Ho FM, Chao KF, Kuo ML, and Liu SH. Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-κB activation and cyclooxygenase-2 expression in mesangial cells. Mol Pharmacol 66: 187-196, 2004.
42. Sheu ML, Ho FM, Yang RS, Chao KF, Lin WW, Lin-Shiau SY, and Liu SH. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol 25: 539-545, 2005.
43. Steffes MW, Schmidt D, McCrery R, Basgen JM; International Diabetic Nephropathy Study Group. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113, 2001.
44. Thabut G, El-Benna J, Samb A, Corda S, Megret J, Leseche G, Vicaut E, Aubier M, and Boczkowski J. Tumor necrosis factor-α increases airway smooth muscle oxidants production through a NADPH oxidaselike system to enhance myosin light chain phosphorylation and contractility. J Biol Chem 277: 22814-22821, 2002.
45. Tsiani E, Lekas P, Fantus IG, Dlugosz J, Whiteside C. High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor. Am J Physiol Endocrinol Metab 282: E161-E169, 2002.
46. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, and Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274: 22699-22704, 1999.
47. Wang L, Flannery PJ, and Spurney RF. Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 142: 313-321, 2003.
48. Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, Kuick RD, and Wiggins RC. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 16: 2953-2966, 2005.
49. Wolf G and Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999.
50. Wolf G, Chen S, and Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626-1634, 2005.
51. Wolf G, Neilson EG, Goldfarb S, and Ziyadeh FN. The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 176: 902-909, 1991.
52. Wolf G, Reinking R, Zahner G, Stahl RA, and Shankland SJ. Erk 1,2 phosphorylates p27Kip1: Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells. Diabetologia 46: 1090-1109, 2003.
53. 2 production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases. Antioxid Redox Signal 7: 526-537, 2005.
54. Xu ZG, Yoo TH, Ryu DR, Cheon Park H, Ha SK, Han DS, Adler SG, Natarajan R, and Kang SW. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int 67: 944-952, 2005.
55. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, and Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276: 25096-25100, 2001.
56. Zeng L, Xu H, Chew TL, Chisholm R, Sadeghi MM, Kanwar YS, and Danesh FR. Simvastatin modulates angiotensin II signaling pathway by preventing Rac1-mediated upregulation of p27. J Am Soc Nephrol 15: 1711-1720, 2004.